Literature DB >> 34225580

Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.

Wei Zhou1,2, Ziyi Chen3, Xizhuo Sun2, Nanshan Zhong4, Zhigang Liu1,2.   

Abstract

A novel coronavirus named SARS-CoV-2 is causing the severe acute pneumonia (COVID-19) and rapid spread nationally and internationally, resulting in a major global health emergency. Chinese governments and scientists have implemented a series of rigorous measures and scientific research to prevent and control the SARS-CoV-2 infection. However, there is still no specific antiviral drug or vaccine against SARS-CoV-2. It has been proven that traditional Chinese medicine (TCM) exerts an important role in the prevention and treatment of the COVID-19 caused by SARS-CoV-2 during the outbreak. Although the therapeutic effects of these TCM formulas are attractive, the molecular mechanism of action has not been fully elucidated. An emerging strategy of systems pharmacology has been proposed to be a promising method to interpret drug action in complex biological systems and quickly screen out the bioactive compounds from TCM to treat treatment of COVID-19 caused by SARS-CoV-2. Therefore, in this study, the epidemiology, TCM therapy, and the systems pharmacology-based method for TCM are reviewed for COVID-19 to provide a perspective for the prevention and treatment of SARS-CoV-2 infection. Further efforts should be made to reduce disease burden and improve the ability to design antiviral drugs and vaccines, which will benefit the health care system, economic development and even social stability.

Entities:  

Keywords:  COVID-19; Drug Discovery; Review; SARS-CoV-2; Systems Pharmacology; Traditional Chinese Medicine

Year:  2021        PMID: 34225580     DOI: 10.1142/S0192415X21500506

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  1 in total

1.  Modulating effect of Xuanfei Baidu granule on host metabolism and gut microbiome in rats.

Authors:  Qiaoyu He; Yumeng Shi; Hong Xing; Qian Tang; Jing Liu; Chunxia Li; Han Zhang; Boli Zhang; Junhua Zhang; Xiaopeng Chen
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.